RAMIREZ, GIUSEPPE ALVISE
 Distribuzione geografica
Continente #
EU - Europa 4.136
NA - Nord America 3.131
AS - Asia 2.886
SA - Sud America 462
Continente sconosciuto - Info sul continente non disponibili 243
AF - Africa 82
OC - Oceania 35
Totale 10.975
Nazione #
US - Stati Uniti d'America 2.963
RU - Federazione Russa 2.156
IT - Italia 962
CN - Cina 943
SG - Singapore 913
BR - Brasile 374
HK - Hong Kong 283
VN - Vietnam 254
SE - Svezia 233
DE - Germania 176
GB - Regno Unito 148
FR - Francia 137
BD - Bangladesh 122
IN - India 107
CA - Canada 87
FI - Finlandia 66
NL - Olanda 57
MX - Messico 42
TR - Turchia 42
PL - Polonia 38
AU - Australia 34
JP - Giappone 34
ES - Italia 33
AT - Austria 32
AR - Argentina 31
ZA - Sudafrica 31
IQ - Iraq 29
ID - Indonesia 24
EG - Egitto 18
CO - Colombia 17
IE - Irlanda 17
IR - Iran 17
MY - Malesia 17
LT - Lituania 16
PK - Pakistan 15
BE - Belgio 14
EC - Ecuador 13
UA - Ucraina 13
SA - Arabia Saudita 12
TN - Tunisia 11
JM - Giamaica 9
MA - Marocco 9
PH - Filippine 9
IL - Israele 8
JO - Giordania 8
CR - Costa Rica 7
PY - Paraguay 7
CL - Cile 6
KE - Kenya 6
PT - Portogallo 6
TH - Thailandia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CY - Cipro 5
DO - Repubblica Dominicana 5
NP - Nepal 5
BG - Bulgaria 4
RO - Romania 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
HR - Croazia 3
KR - Corea 3
MD - Moldavia 3
NI - Nicaragua 3
BO - Bolivia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
LB - Libano 2
MT - Malta 2
PE - Perù 2
RS - Serbia 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
Totale 10.723
Città #
Singapore 496
Ashburn 400
Moscow 387
San Jose 335
Dallas 310
Hong Kong 269
Milan 228
Beijing 176
Shanghai 172
New York 170
Council Bluffs 126
Los Angeles 114
Hefei 106
Rome 101
Ho Chi Minh City 94
Lauterbourg 91
Santa Clara 88
Boardman 80
Munich 69
Hanoi 60
Orem 53
Princeton 43
Lawrence 42
Nuremberg 39
Denver 38
São Paulo 36
Chennai 35
Helsinki 35
London 34
Warsaw 33
Atlanta 32
Tokyo 31
Montreal 29
Chicago 28
Brooklyn 27
Ankara 23
Guangzhou 23
Houston 23
Poplar 22
Rio de Janeiro 22
Bologna 20
Seattle 20
Manchester 19
Mexico City 19
Toronto 19
Bari 18
Genoa 18
Washington 18
Boston 17
Turku 17
Falkenstein 16
Mumbai 16
Amsterdam 15
Johannesburg 15
San Francisco 15
Stockholm 15
Da Nang 14
Phoenix 14
Dublin 13
Vienna 13
Belo Horizonte 12
Buffalo 12
Baghdad 11
Brussels 11
Cagliari 11
Cape Town 11
Cesano Boscone 11
Frankfurt am Main 11
Lappeenranta 11
Naples 11
Pune 11
Catania 10
Changsha 10
Figino 10
Hải Dương 10
Shenzhen 10
The Dalles 10
Wollongong 10
Cairo 9
Kuala Lumpur 9
Memphis 9
Palermo 9
Philadelphia 9
Secaucus 9
Turin 9
Brisbane 8
Central 8
Cincinnati 8
Istanbul 8
New Delhi 8
Pietra Ligure 8
Querétaro 8
Sydney 8
Amman 7
Columbus 7
Florence 7
Haiphong 7
Hangzhou 7
Melbourne 7
Miami 7
Totale 5.220
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 399
Multidirectional dysfunction of the immune response in patients with systemic lupus erythematosus 374
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 308
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 221
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 212
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 184
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 179
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 156
A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-centre cohort 154
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 153
Biobanking for COVID-19 research 149
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 138
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 137
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 137
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature 133
LENGTH OF STAY IN INTERNAL MEDICINE: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 131
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 130
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 130
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 127
PTX3 intercepts vascular inflammation in systemic immune-mediated diseases 126
Influence of reduced muscle mass and quality on ventilator weaning and complications during intensive care unit stay in COVID-19 patients 125
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 122
A continuity care program in chronic, complex and frail patients: the PRO-CCF study protocol 122
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 120
Urgent manifestations of immunoglobulin G4-related disease 118
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases 115
Testosterone in males with COVID-19: A twelve-month cohort study 114
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 114
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 113
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19 112
HOSPITALIZATION COURSE AND OUTCOMES OF CANCER PATIENTS ADMITTED TO INTERNAL MEDICINE UNITS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 112
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 111
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 110
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 110
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 109
Severely low testosterone in males with COVID-19: a case-control study 109
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 108
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 107
Chromogranin A plasma levels predict mortality in COVID-19 106
COVID-19: Pharmacology and kinetics of viral clearance 105
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 103
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 101
A CASE OF PRIMARY ADRENAL EBV+ EXTRANODAL NK/T-CELL LYMPHOMA 101
Sustainability in Internal Medicine: A Year-Long Ward-Wide Observational Study 100
Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study 98
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 96
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 96
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 95
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) PRESENTING WITH THYROID DYSFUNCTION: A CASE REPORT 94
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 93
Infection-Associated Flares in Systemic Lupus Erythematosus 92
Choroidal Neovascularization in a Patient with Crohn's Disease 92
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 90
Testosterone in males with COVID-19: A 7-month cohort study 90
INTRODUCING SUSTAINABILITY IN MEDICINE:THE SIM STUDY 90
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 89
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 88
DIFFERENTIAL PROFILES OF BACTEREMIA IN EMERGENCY AND MEDICINE DEPARTMENTS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 88
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 88
MACROPHAGE ACTIVATION SYNDROME IN EARLY SYSTEMIC LUPUS ERYTHEMATOSUS: A CLINICAL CASE REPORT 87
Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis 85
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 85
Six-month respiratory outcomes and exercise capacity of COVID-19 acute respiratory failure patients treated with continuous positive airway pressure 84
PYODERMA GANGRENOSUM REVEALING TAKAYASU ARTERITIS IN A 65-YEAR-OLD CAUCASIAN WOMAN: A CASE REPORT 83
INTRODUCING A NOVEL HOSPITAL-TO-HOME CARE PROGRAMME IN CHRONIC/COMPLEX/FRAIL PATIENTS: THE PRO-CCF STUDY 83
EFFICACY AND SAFETY OF CONTINUOUS POSITIVE AIRWAY PRESSURE AND PATIENT MOBILIZATION FOR ARDS DUE TO COVID-19 IN A NON-ICU SETTING 82
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 81
Choroid plexus and perivascular spaces enlargement in neuropsychiatric systemic lupus erythematosus 81
Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice 81
Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors 78
SECOND AND THIRD LINE ANTIMICROBIAL THERAPY IN INTERNAL MEDICINE DEPARTMENTS: A PROSPECTIVE ANALYSIS ON PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 77
Selective serotonin reuptake inhibitors and fractures in older nursing home residents: Data from the INCUR study 77
Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation 77
Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis 77
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 77
Platelet prothrombotic activity in COVID-19 survivors with persisting respiratory symptoms after 2 years from hospital discharge 76
Neutrophil Extracellular Traps in the Autoimmunity Context 76
Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine 76
NONBACTERIAL THROMBOTIC ENDOCARDITIS AND DIFFUSED INTRAVASCULAR COAGULATION IN RAPIDLY PROGRESSING PROSTATIC ADENOCARCINOMA: A CLINICAL CASE 74
WHIPPLE’S BACKLASH: IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. A CASE REPORT 73
BEHEADED MENINGITIS: A CASE REPORT 72
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 71
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 71
PLASMA AND TISSUE EXPRESSION OF PTX3 IN PATIENTS WITH CHRONIC PERIAORTITIS 71
Quantitative MRI adds to neuropsychiatric lupus diagnostics 70
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 69
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 68
DISCORDANT DIAGNOSIS OF PULMONARY LYMPHOMATOID GRANULOMATOSIS AND EBVNEGATIVE DIFFUSE LARGE B-CELL LYMPHOMA IN THE SAME PATIENT, A CASE REPORT 67
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 67
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): Cross-sectional analysis 64
Evidence for charge-based mimicry in anti dsDNA antibody generation 62
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTRE REAL-LIFE EXPERIENCE 61
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): Prospective study 61
Misunderstandings between platelets and neutrophils build in chronic inflammation 60
COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients 60
IgG4-related disease and allergen-specific immunotherapy 58
Colchicine treatment in community healthcare setting to prevent severe COVID-19. 58
Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms 57
Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives 56
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 50
Totale 10.667
Categoria #
all - tutte 49.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022160 0 0 2 22 4 22 9 12 15 9 30 35
2022/2023510 112 93 48 18 25 55 46 53 13 10 19 18
2023/2024708 26 42 72 61 54 142 41 67 15 28 57 103
2024/20251.967 129 67 97 98 151 177 231 211 208 174 153 271
2025/20266.941 517 420 379 805 581 238 588 552 1.912 414 305 230
2026/2027655 328 327 0 0 0 0 0 0 0 0 0 0
Totale 10.975